Funding

The Epigenetic Etiology of Human Disease Lab at Mayo Clinic receives ongoing research support from several sources within the National Institutes of Health.

Grants

Investigator & Role Grant Title Funding Source Duration
Keith D. Robertson, Ph.D., principal investigator Synthetic lethal targeting of SETD2 in renal cell carcinoma (R01 CA271503) National Cancer Institute 2/2023 to 1/2028
Keith D. Robertson, Ph.D., principal investigator RNA methylation as a novel effector of SETD2 in kidney cancer (R21 CA283539) National Cancer Institute 4/2024 to 3/2026